157 related articles for article (PubMed ID: 3127104)
21. Serum levels of IgG, IgM, and IgA in rheumatoid arthritis.
Veys EM; Claessens HE
Ann Rheum Dis; 1968 Sep; 27(5):431-40. PubMed ID: 4175666
[No Abstract] [Full Text] [Related]
22. Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.
Tarkowski A; Nilsson LA
J Clin Lab Immunol; 1983 Nov; 12(3):129-35. PubMed ID: 6663605
[TBL] [Abstract][Full Text] [Related]
23. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.
Swedler W; Wallman J; Froelich CJ; Teodorescu M
J Rheumatol; 1997 Jun; 24(6):1037-44. PubMed ID: 9195506
[TBL] [Abstract][Full Text] [Related]
24. Latex agglutination assay for human anti-Brucella IgM antibodies.
Cambiaso CL; Limet JN
J Immunol Methods; 1989 Sep; 122(2):169-75. PubMed ID: 2794512
[TBL] [Abstract][Full Text] [Related]
25. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients.
Hanly JG; Hassan J; Whelan A; Feighery C; Bresnihan B
Arthritis Rheum; 1986 Apr; 29(4):480-7. PubMed ID: 3707625
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.
van Zeben D; Hazes JM; Zwinderman AH; Cats A; van der Voort EA; Breedveld FC
Ann Rheum Dis; 1992 Sep; 51(9):1029-35. PubMed ID: 1417131
[TBL] [Abstract][Full Text] [Related]
27. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
28. Fall in immune complex levels during gold treatment of rheumatoid arthritis.
Highton J; Panayi GS; Shepherd P; Faith A; Griffin J; Gibson T
Ann Rheum Dis; 1981 Dec; 40(6):575-9. PubMed ID: 6800312
[TBL] [Abstract][Full Text] [Related]
29. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
30. Enzyme linked (ELISA) immunoabsorbent assay for the detection of hidden 19S IgM rheumatoid factors in juvenile rheumatoid arthritis.
Moore TL; Dorner RW; Alexander RL; Osborn TG
J Rheumatol; 1988 Jan; 15(1):87-90. PubMed ID: 3351844
[TBL] [Abstract][Full Text] [Related]
31. Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis.
Robbins DL; Feigal DW; Leek JC
J Rheumatol; 1986 Apr; 13(2):259-62. PubMed ID: 3723492
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunoassay for IgG and IgM rheumatoid factors.
Sesso RC; Nishida SK; Alves MA; Ramos OL; Pereira AB
Braz J Med Biol Res; 1986; 19(3):395-401. PubMed ID: 3594005
[TBL] [Abstract][Full Text] [Related]
33. Detection of IgG rheumatoid factor by concanavalin A treatment and complement fixation with IgG rheumatoid factor.
Tanimoto K; Moritoh T; Azuma T; Horiuchi Y
Ann Rheum Dis; 1976 Jun; 35(3):240-5. PubMed ID: 984904
[TBL] [Abstract][Full Text] [Related]
34. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
Rudge SR; Pound JD; Bossingham DH; Powell RJ
J Rheumatol; 1985 Jun; 12(3):432-6. PubMed ID: 3930719
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
Crawhall JC
Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
[TBL] [Abstract][Full Text] [Related]
36. [Dissociation tests of serum protein fractions with special reference to the rheumatoid factor].
Götz H; Scheiffarth F; Krauss P
Z Rheumaforsch; 1969; 28(9):328-40. PubMed ID: 4982338
[No Abstract] [Full Text] [Related]
37. Circulating protein complexes in D-penicillamine therapy of rheumatoid arthritis. Correlation between IgG- and alpha 1-antitrypsin-IgA complexes and clinical response.
Norberg R; Wollheim FA; Gedda PO
Acta Med Scand; 1980; 208(5):393-6. PubMed ID: 6969974
[TBL] [Abstract][Full Text] [Related]
38. Chrysotherapy. Suppression of immunoglobulin synthesis.
Lorber A; Simon T; Leeb J; Peter A; Wilcox S
Arthritis Rheum; 1978; 21(7):785-91. PubMed ID: 100121
[TBL] [Abstract][Full Text] [Related]
39. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
Schmidt KL; Ott VR
Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
[TBL] [Abstract][Full Text] [Related]
40. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
